• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:

    公开号:SE0950299A1
    申请号:SE0950299
    申请日:2009-05-04
    公开日:2010-11-05
    发明作者:Siegbert Warkentin；Catarina Erikson
    申请人:
    IPC主号:
    专利说明:

    10 relevant information, working memory) and speed in information processing (they process information more slowly than their peers). These weaknesses are often interrelated and can, individually or in combination, contribute to the child's difficulties with literacy, numeracy and academic success.
    For example, children with either the Inattentive or Combined subtypes of ADHD may have difficulty retaining information in working memory long enough to be able to perform the necessary mental calculations to arrive at an answer. In addition to possible limitations in their working memory range, children and adolescents with the disorder are often slower in their ability to process information (information processing speed). _ Some possible reasons for this may relate to certain reported pathophysiology (s). ) in the event of the disturbance. Although the results are inconsistent, studies have shown a delay in the development of certain brain structures (ie the frontal, temporal and parietal cortical areas) while other structures such as the motor cortical area mature more rapidly. Studies have also shown a developmental delay in the maturation of the brain's white matter. Myelination of axonal processes is a relatively slow and sensitive process that continues into middle age. A developmental delay in white matter streaks will affect the rate at which the brain can process information and will also affect the rate of interaction between different cortical and subcortical areas connected by these streaks. Follow-up studies have provided evidence that a developmental delay begins very- (with magnetic et early in life. Studies of brain morphology resonant tomography) have, for example, shown a smaller brain volume in young children with ADHD. Although the brains of children with and without ADHD develop in parallel and at the same rate, this difference in brain volume persists into adolescence and probably into adulthood.
    In addition to these pathophysiological and morphological findings in ADHD sufferers, environmental causes such as heavy metals, food additives and sugar have also been implicated in the etiology of this condition.
    Stimulant medication is one of the commonly used treatments for ADHD and is often used to relieve ADHD symptoms, such as hyperactivity and impulsivity. Although the use of such medications is increasingly being debated, they have shown positive effects, e.g. on cognitive function, including processing speed.
    There is a need to test, facilitate diagnostics, or diagnose ADHD. A practical and non-invasive way is to analyze the patient's speech.
    Tannock et al (2000) the study that stimulating medication affects name-reported the first rate of miracle. They found that children with ADHD were reduced in color naming rate regardless of simultaneous reading disability, while methylphenidate improved the naming rate in these children. Other conclusive evidence has shown that the often reported higher variability in response (denomination rate independent of stimulus) in ADHD is reduced by methylphenidate treatment.
    US 6,350,288 describes a fast automated method and apparatus for naming. The technology provides a method for analyzing reading and attentional abilities that consists of recording and digitizing sound waves generated by a subject's voice in response to a series of stimuli.
    Each sound wave is broken down into a sequence of accumulated periods of articulations and pauses and this information is used in relation to reading and attention abilities in children. However, neuropsychiatric disorders are not mentioned in US 6,350,28. In addition, phonological production (articulation time) is a less sensitive measure of higher-order cognitive processes performed by the brain. The method and apparatus according to US 6,350, l28 are also dependent on culture and education.
    US2004 / 0058306 describes a word-based test, and a method for testing the function of the parietal lobe and in particular for Alzheimer's disease. US2004 / 0058306 utilizes first-order color stimuli, systems, and first-order forms, letters, numbers, animals, and objects, as well as random combinations of colored shapes, letters, numbers, animals, and objects. In the main phase of the administration of the test, three trials are administered to determine the degree of adequacy in naming visual stimuli. First, the subject is asked to practice by naming different colors, then different shapes and then different combinations of the two. The test then begins with naming 40 colors shown in always with color as the first to be named. uniform shapes as quickly as possible. Stimulina is displayed in random order on a disc. Then the same number of different black shapes should be named. The same procedure is then repeated with randomly displayed combinations of the two that the subject is asked to name as quickly as number animals and objects. The total term of each stimulus, possible. The same procedure can be repeated with letters, rudders, and one of the subtests and the total number of incorrect names of stimuli are evaluated and presented in a graph.
    However, the duration of the speech pause in time is not determined. In addition, no measurement is provided for separate components in brain function, such as a component for processing to identify stimuli, or a component for memory retrieval. For example, in naming tasks with a large number of stimuli (eg naming about 40 different shapes and colors and their combinations in succession), it is not possible to determine in a reliable way which shape or color or combination of these is identified by visual stimuli. - ring. The total time needed for the naming tasks consists of a mixture of many different components in brain activity, which cannot be identified individually from the total naming time. For example, it cannot be deduced which specific stimuli of a large number of stimuli showed during a naming task that are processed during which part of the naming time. This is primarily due to the brain's ability to process in parallel and the phenomenon of "chunking", ie. the loading into the memory of several stimuli in a sequence which is performed before utterance and which is a well-known phenomenon when reading. In addition, the naming time is given only as an average measure from a longer period of time with sequential naming of a large number of stimuli provided simultaneously.
    An improved test method for determining brain function would thus be advantageous, to allow more detailed analysis of separate components in brain function.
    In addition, various methods and devices are known for US 5,9ll, 58l describes, for example, a method and apparatus for measuring and analyzing mental to test mental ability. ability. One aspect of US 5,911, 581 describes the evaluation of reaction time using a subliminal consciousness threshold test where the contour of a stimulus unfilled) is to be separated from a filled stimulus at the right time. The display time of the contoured stimulus begins at a (ie subliminal threshold and the display time is then increased gradually until a subject can determine whether the contoured After three correct answers from a subject is set the display time of the stimulus came before the filled stimulus. contoured stimulus in for continued use, however, US, 9ll, 58l is not based on speech analysis, which would be more advantageous since voice-based testing of mental abilities would be easier to perform.US US 5.9ll, 58l also says nothing about diagnostics of disorders related to or to The brain, including neuropsychiatric disorders, is a diagnosis of the same. correctly in the correct order, to thereby evaluate this subject m inside for serial processing and retrieval speed of memories. Retrieval speed is measured with digital or computerized timers, but no voice recording is performed. In another embodiment of the technology, a speedometer (Cognometer) is presented. This device measures the difference between the time required to copy the figure data and the time used to perform an arithmetic calculation on such figures and enter the results. The latency or the time to copy or subtract or add a number is measured from the entry of the digit on the screen to the input of the first digit of the two, however, US5230629, US4770636 does not mention any use for diagnostics of the numeric response number. The references US2003l8l793, neuropsychiatric disorders and are troublesome and not based on voice analysis.
    The known methods and devices may not be culture and education independent. Tests performed with the known methods and devices can therefore be influenced by the cultural and educational background of the patients who undergo diagnosis or testing of disorders related to the brain, including neuropsychiatric disorders.
    There is thus a need for universal, culture- and education-independent diagnostics or testing.
    Adjustment of medication for disorders related to the brain, including neuropsychiatric disorders, based on voice analysis, is not described in any of the documents referred to above. However, there is a need to provide a simple way of adjusting such medication to the specific needs of a patient. Thus, there is a need to be able to provide a reliable adjustment of the medication dose to the specific needs of the patient.
    There is also a need to be able to provide a relative measure of the relative contribution of specific brain activity components to the total brain activity.
    An improved apparatus and method would thus be advantageous, and in particular those which allow increased flexibility, cost efficiency, reliability, versatility, independence and / or patient friendliness would be advantageous.
    SUMMARY OF THE INVENTION Thus, the embodiments of the present invention seek to alleviate, alleviate or eliminate one or more shortcomings, disadvantages or problems in the art, as those identified above, alone or in any combination, by providing an apparatus, method and method. computer programs in accordance with the appended claims.
    Processing speed is a general and inherent aspect of brain function and the brain's ability to quickly process information is intricately linked to all mental operations. This function can be measured in many different ways and for all modalities. The awake brain is constantly exposed to visual information that needs to be processed. The speed at which visual processing takes place can be measured, for example, by asking a subject to pronounce the name of a visually presented stimulus. Processing speed is the summed time for all the individual computational steps that the brain uses to allocate attention and to visually recognize and categorize the stimulus, to decode and retrieve the stimulus from working memory, to perform phoneme processing, and finally to finally get the speech machine to utter the stimulus. Any disturbance (morphological or neurochemical) of brain areas needed to perform all these calculations will inevitably lead to a reduction in the rate at which such information is processed and finally pronounced.
    The computational processing time for a visual stimulus before a subject utters the stimulus is defined here as the “duration of the pause time” or the duration of the pause time until the beginning of the articulation.
    The present invention takes advantage of this duration of the pause as a measurable parameter to facilitate the diagnosis of brain-related dysfunctions, such as neuropsychiatric dysfunctions.
    In addition, processing time, and in particular the duration of speech pauses between stimulus statements, is a very sensitive measure of brain dysfunction in neurodegenerative disorders. The duration in time for this speech break is a predictor of learning and reading abilities in children and the duration in time of the speech break decreases with stimulating medication. However, the duration of the speech pause does not provide a measure of separate components of brain function, such as a processing component for identifying stimuli, or a memory retrieval component. For example, in naming tasks with a large number of stimuli (eg naming 40 different shapes and colors and their combinations in succession), it cannot be reliably determined which shape or color is identified by visual stimulation. Talpaustiden, e.g. in naming tasks, consists of a mixture of many components of brain activity, which can not be identified individually from the speech pause time due to the brain's ability to parallel processing and / or grouping (chunking) of stimuli in working memory before utterance. In the prior art, it can not be deduced which specific stimuli of a large number of stimuli showed during a naming task that are processed during which part of the speech pause time. In addition, the speech pause time 10 is often provided only as an average measure, from a longer period of time with sequential naming of a large number of stimuli provided simultaneously, in relation to total speaking time.
    According to a first aspect of the invention, an apparatus is provided. The device is arranged to diagnose disorders related to a subject's brain.
    The apparatus comprises a stimulus display unit for said subject, a microphone for recording an audio signal, and a control unit arranged to determine a time for recognizing a stimulus as a first pause time component, in a first operating step, to determine a time for retrieving memory for a stimulus as a second pause time component, in a second work step, and subsequently displaying on said display unit a predefined number of different stimuli individually and in an order, each of the stimuli displayed during said time for recognition and with a display pause of predefined length between said individual displays, and, after the display of the last stimuli is completed, measuring a pause time until the articulation of said subject begins in said audio signal, to name the displayed stimuli as quickly as possible and in said order, in a third work step repeated a predefined number of times.
    According to a second aspect of the invention, there is provided a method of diagnosing disorders related to a subject's brain, using a voice signal.
    The method comprises: a first step of determining a time for recognizing a stimulus as a first pause time component, a second step of determining a memory retrieval time for a stimulus as a second pause time component, and then a predefined number of times a third step of: displaying a predefined number of different stimuli individually and in sequence, each of the stimuli being displayed during said time for recognition and with a display pause of predefined length between said individual displays, and that, after the display of the last stimuli is completed, measure a pause time until said subject articulation begins to name the displayed stimuli as quickly as possible and in said order.
    According to a further aspect of the invention there is provided a computer program for processing with a computer. The computer program is for diagnosing disorders related to the brain, by using a voice signal.
    The computer program is designed for processing with a computer, the computer program comprising a plurality of code segments, including a first code segment for determining a time for recognizing a stimulus as a first pause time component, a second code segment for determining a time for memory retrieval for a stimulus as a second pause time component, and a third code segment, for subsequent execution and a predefined number of times, for displaying a predefined number of different stimuli individually and in sequence, each of the stimuli displayed during said time for recognition and with a display pause of predefined length between said individual displays and, after the display of the last stimuli is completed, measuring a pause time until said subject's articulation begins to name the displayed stimuli as quickly as possible and in said order In one embodiment, the computer program is designed on a computer readable medium.
    Further embodiments of the invention are defined in the dependent claims, the features of the second and subsequent aspects of the invention, with appropriate modifications, being the same as the first aspect.
    Some embodiments of the invention provide a relative power on the relative contribution of specific components of brain activity to total brain activity. Some embodiments of the invention provide an adjustment of medication dose or type through an identification of components of brain activity.
    One component of brain activity that can be measured is, for example, the processing time for identifying a stimulus.
    Applicants have realized that this component is an important component, for example in the diagnosis of ADHD. This component is also affected by specific medications that have a drug effect on cerebral processing.
    Another component of brain activity that can be measured is, for example, the processing time for memory retrieval. Applicants have realized that this component is another important component, for example in the diagnosis of ADHD. This component is also affected by specific medications that have a drug effect on cerebral memory.
    In this way, an optimal adjustment of medication can be provided, e.g. through a combination of different drugs that affect specific components of brain activity.
    Some embodiments of the invention provide for drug development. Specific drugs can be developed and the effect tested on subjects using the present method and apparatus. An improvement in one or more specific components of brain activity can be determined, as an effect of a specific medication.
    In the embodiments, an analysis of an audio file is performed which, however, is different from what is known previously. An object offered by the present invention is to measure the relative contribution of several specific components of the duration of the pause time that occurs before the oral utterance of visual stimuli. Pause time is the time when the brain performs many cognitive processes of higher and lower order, before speech is articulated. The duration of this silent processing involves many different skills of the brain and is in itself related to the rate of visual scanning, the rate of stimulus discrimination and categorization, the decoding rate, retention in and retrieval from working memory, and the rate of formation of the phonological mechanisms that are useful for pronouncing visual stimuli. These processes are universal and independent of culture and education. The public articulation of stimuli is therefore the end product of these above-mentioned mental processes and it has been shown in the field of technology that the articulation time is not related to the duration of the pause time. Since phonological production (articulation time) is a much less sensitive measure of these processes, it is therefore disregarded in the present invention.
    Some embodiments also use a memory principle with serial processing, by showing four random colors or shapes, e.g. on a screen, to be named correctly and in the correct order by a subject. At the beginning of the display of stimuli, a voice recording evaluates the duration of the pause time that occurs during the download phase for the stimuli displayed in sequence. The display of stimuli in a sequence can be repeated to give a reliable measure of the average pause duration for each of the individual stimuli. The evaluation of retrieval time in the present invention clearly differs from the prior art in that the memory retrieval is considered here and used as a component of the duration of the pause time preceding the articulation of the stimulus. The duration of the pause time recorded during the retrieval and the verbal naming of individual stimuli are thus used by the present invention as a component in the analysis of pause time in the sequential processing of discrete stimuli. The description in USZOO4 / 0058306 clearly differs from the present invention in several important points.
    First, although the stimulus according to the present embodiments also involves different colors and shapes, the present invention is based on the evaluation of voice recordings in the designation of the stimulus and in particular on the evaluation of the duration of the pause time which occurs before the utterance of stimulin. This is not done in the description according to US2004 / 0058306.
    Secondly, the present embodiments utilize the evaluation of the time for recognition and memory retrieval and their respective contributions to the duration of the pause time. This is not done in the description according to US2004 / 0058306.
    Third, the display of stimuli in the present embodiments consists of discrete stimuli, in contrast to the mentioned technique. The two stimuli (color and shape) are displayed at 0.1 second intervals as the normal value. This is not the case in the mentioned technique, where all stimuli are displayed immediately and no account is taken of the control of the interstimulus interval. The intentional separation of the stimulus with a short time interval of display time allows the present embodiments to control the time interval between stimuli, in order to test the working memory capacity of subjects. This is not possible through the description according to US2004 / 0058306.
    Fourth, the color and shape combinations according to the present embodiments can each be displayed in a discrete sequence, i.e. a color and a shape can be displayed in random order, while voice recording evaluates the duration of the pause time. In contrast to the mentioned technique, the number of individual sequences of such stimuli shown in pairs can easily be increased or decreased.
    It should be emphasized that the term "includes" when used in this specification has been chosen to specify the presence of specified features, units, steps or components, but does not exclude the presence or supply units, components of a / or several other features, steps, nents or groups of the same.
    Brief Description of the Drawings These and other aspects, features and advantages to which the embodiments of the invention are capable will become apparent and illustrated by the following description of embodiments of the present invention, taken in conjunction with the accompanying drawings, in which: Figs. is a schematic illustration of a method for identifying a time for stimulus recognition - step one in an embodiment of a method, Fig. 2 is a schematic illustration of identifying a time for memory retrieval - step two in an embodiment of a method, Fig. 3 is a schematic illustration of stimulus display and sound recording - step three in an embodiment of a method, Fig. 4 is a schematic illustration of an embodiment of an apparatus for performing the method, Fig. 5 is a schematic illustration of an embodiment of the method, Fig. 6 is a schematic illustration of the units of the apparatus, Fig. 7 is a schematic illustration of an embodiment of the apparatus. snake of a computer program, Fig. 8 is a graph illustrating the duration of the pause in healthy as well as dysfunctional, non-medicated persons of different ages, Fig. 9 is a schematic illustration of the difference in the duration of the pause between a drug-free and a medic. - the condition in patients, and Fig. 10 is a schematic illustration of the difference in the variability of the pause period between a drug-free and a medicated condition in patients.
    Description of Embodiments Specific embodiments of the invention will now be described with reference to the accompanying drawings.
    However, the present invention may be given many different forms and should not be construed as being limited to the embodiments set forth herein, rather so that the present description becomes thorough but these embodiments are provided and complete and will allow those skilled in the art to fully understand the scope of the invention. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numerals refer to like parts.
    The following description concentrates on an embodiment of the present invention which is useful for the diagnosis of neuropsychiatric disorders and in particular for the diagnosis of ADHD. It will be appreciated, however, that the invention is not limited to this application but may be used for many other neuropsychiatric disorders, including, for example, autism and autism spectrum disorders, Asperger's syndrome, or brain injury disorders such as Alzheimer's disease, Multiple sclerosis (MS) or any other subcortical white matter or demyelinating disease, HIV, malaria, cerebrovascular disease (VaD), encephalitis, traumatic brain injury (TBI), mild cognitive impairment (MCI), fronto-temporal dementia (LBD) / DLB), (FTD / FLD), dementia with Lewy body disease Parkinson's disease (PD) and vascular dementia.
    Embodiments of the invention are described in detail below with reference to Figures 1 to 7. 10 16 How to perform the measurement The measurement is performed in three steps, depicted in Figures 1, 2, 3 and 4.
    Normal stimuli are four different colors and four different shapes. These steps are performed in a fixed order. but the method is not limited to these stimuli. In other embodiments, alternatively or in addition, other stimuli may be used, e.g. other visual stimuli, such as images, auditory stimuli, etc. The method is thus implemented in an educational and culturally free manner and the mentioned measurements do not include questions related to the subject's knowledge.
    Step 1 of a stimulus - which is part of the pause time measured in Step 3).
    (Figure 1. Evaluation of the time for recognition The experimenter tests at which display time for stimulus the subject can correctly identify and name the stimulus. The display time for stimulus can be changed with discrete steps ranging from the lowest level of 0.1 seconds up to the maximum level 1.0 second The experimenter establishes the lowest level for correct identification of the stimulus through the correct verbal response from the subject.Once this display time has been identified, the experimenter (or subject) presses the OK button on the device 4 (figure 4 This OK signal is then used auto- In this way, a reliable and correct identification is mathematically ensured as the display time of the stimulus in Step 3. of the stimulus at a minimum display time.Thus, the component display time of a stimulus - which is part of pause - it - is determined in a reliable way.
    Step 2. a stimulus or test of working memory - which is a part (Figure 2. Evaluation of the retrieval time for of the pause time measured in Step 3). 10 17 The four color stimuli used as normal stimuli are displayed on the device screen (Figure 4) with the set display time defined in Step 1. The stimulus is displayed in successive order at one-second intervals until all stimuli have been displayed. The subject is instructed to name the four color stimuli correctly and in the correct order as soon as all four stimuli have been displayed.
    At the beginning of the last stimulus, voice recording starts and the pause time is analyzed automatically. The retrieval time for each individual stimulus is calculated as the average pause time for all four stimuli divided by four. The value is stored automatically and used by the device to calculate the amount of retrieval time that contributes to the total pause time that occurs in Step 3.
    This procedure can be repeated for a second series of four different forms. stimuli, e.g.
    This is a test of short-term memory. By dividing the total pause time by the number of stimuli, the time for memory retrieval for a stimulus is determined.
    In other embodiments, a different number of stimuli may be used.
    Step 3. stimuli showed in pairs).
    (Evaluation of the duration of the pause time at Here the display time for stimuli set in Step 1 is used. The two stimuli (color and shape) are separated by 0.1 second as a normal value, to thereby form two discrete stimuli. This normal value is a dynamic special features of the method and can be increased, eg to test a memory component specifically with the present testing.
    The individual stimuli as well as the order of the pairwise display of stimuli are randomized (ie, sometimes a color appears as the first stimulus, sometimes a shape appears first). The subject must always name the stimulus display in the correct order. The stimulus first shown must thus be named 18 first. After the onset of the second stimulus, the subject must name the stimulus as quickly as possible.
    Voice recording starts automatically at the beginning of the first stimulus and the duration of the pause time until the first oral utterance of the first stimulus is analyzed. The method automatically subtracts the stimulus display times and interstimulus interval from the recorded audio signal. The degree of contribution that the time for memory retrieval has contributed to the duration of the break is analyzed. In addition, the time for recognition is analyzed. The duration of the total pause time may be longer than the added recognition time and retrieval time, depending on other components of brain activity.
    The signal thus provides a measure of the duration of the total pause and its components.
    Apparatus (Figure 4).
    All 3 steps are performed using the device.
    Step 1 is performed by setting the time for stimulus recognition using a scale, which shows discrete steps ranging from 0.1 to 1.0 seconds. The setting is performed with a button with which the display time for the stimulus can be adjusted upwards (+) and downwards (-). When the minimum display time for a correct recognition and naming of the stimulus has been identified, the OK button is pressed by the experimenter / subject and this stimulus display time is thus set as the normal value of the device.
    Step 2 (Download time / test working memory) is performed in the manner presented above. The sound is recorded using a microphone.
    After Steps 1 and 2 have been completed, the subject can press the START button. At this time, the pairwise stimuli are displayed on the screen according to Step 3.
    The beginning of audio recording starts at the beginning of the first stimulus and stops after the utterance of the 19 second stimulus has taken place. Then it takes 1 second (can be adjusted if necessary) until the next display of stimulus pairs takes place or is started manually. The display sequences run automatically a predefined number of times, e.g. 40 times the normal value. The device automatically stops displaying stimuli according to Step 3, when this number has been reached.
    The individual sequences can also be displayed separately and each separate sequence is started by the experimenter / subject by holding down the START button, which automatically activates the individual sequence.
    Fig. 5 is a schematic illustration of an embodiment of the method, in a flow chart 5, which comprises the above-mentioned steps 1 to 3.
    A method is provided for diagnosing disorders related to a subject's brain, by using a voice signal, said method comprising: a first step of determining a time for recognizing a stimulus as a first pause time component, a second step of determining a memory retrieval time for a stimulus as a second pause time component, and then a predefined number of times a third step of: displaying a predefined number of different stimuli individually and in sequence, each of the stimuli showed during said time for recognition and with a display pause of predefined length between said individual displays, and to, after displaying the last stimuli has been completed, measure a pause time until said subject's articulation begins to name the displayed stimuli so quickly as possible and in said order.
    Stimulins in said method may be a predefined number of different visual and / or auditory stimuli.
    The time for recognizing a stimulus can be determined in said method by testing at which stimulus display time the subject can correctly identify and name the stimulus.
    The display time for the stimulus can be changed in said method with discrete steps from a lower level of 0.1 second to a maximum level of 1.0 second, the said time for recognition being determined as the lowest level for correct identification of the stimulus by the correct verbal response from the subject.
    The time for retrieving memory for a stimulus can be determined in said method by displaying a plurality of said stimuli, each with the display time determined in the first step and in successive order with a time interval between them and that, when the beginning of the display of the last stimulus has ended, record the number of said subjects and analyze the pause time in said speech according to said subject's naming of the stimulus correctly and in the correct order, and to calculate said memory retrieval time as the average pause time for all stimuli divided by the number of stimuli.
    The method may comprise repeating said procedure according to claim 6 for a second series of different stimuli.
    The predefined number of different stimuli in said third step of said method is two in one embodiment.
    The display pause is at least 0.1 seconds in embodiments of the method.
    The individual stimuli as well as the order of display of stimuli in the method may be randomized.
    The method may include recording an audio signal at the beginning of the first stimulus and the duration of the pause time until the first oral utterance of the first stimulus is determined from the recorded signal, and subtracting the stimulus display times and interstimulus interval from the recorded audio signal. the total duration of the pause time and components thereof are provided. 10 21 The method can be carried out with the aid of said apparatus as above.
    The pause time and components thereof can in the mentioned method be used for the diagnosis of neuropsychiatric disorders - including ADHD, eels, disorders within the autism spectrum, or disorders caused by brain damage.
    The pause time and components thereof can be used in said method for an adjustment of medication dose or type of medication to individual patient needs.
    The pause time and components thereof can be used in said method to identify subjects who do not respond to medication when no change in pause time occurs after administration of said medication.
    The pause time and components thereof can in the said method be used for clinical drug testing and for evaluation and effect of said drug on a neuropsychiatric including ADHD, atrial disorder, disorders within the autism spectrum, or disorders caused by brain damage in said subject.
    Fig. 6 is a schematic illustration of units of the apparatus including a control unit 720.
    Fig. 7 is a schematic illustration of an embodiment of a computer program 710, formed on a computer readable medium 750 and comprising code segments 730, 740, 750.
    In the embodiments of the present invention, the evaluation of a correct recognition of a path such as US 5,911, 581 differs. In the embodiments, a correct recognition is evaluated by the mulus from the prior art, successive increase (or decrease) of the display time for the specific stimuli themselves, without reference to a predefined stimulus. The decision at which display time the stimulus is recognized and named correctly and in a stable manner, with reference to itself, is made by the experimental person. The correct naming of the stimulus, not just the correct visual discrimination of the stimulus, is an inherent feature of the present invention. In contrast to US 5,911,58l, the present invention does not evaluate reaction time. Reaction time evaluated by a correct identification of the sequence of stimulus display, as proposed in US 5,911, 581, tt and involves a much earlier visual processor with a much faster hashing phase. Instead, the present invention evaluates the summed end result of the entire series of processing events that take place before a subject can orally name the stimulus correctly. This obtained display time for correct naming of the stimulus is set as a normal parameter and is used in a series of the randomly ordered stimuli that are displayed at 1 second intervals and after which the subject names the stimulus. A voice recording is performed after the last stimulus has been displayed to obtain the average pause time duration when naming the individual stimulus to obtain the time component for memory retrieval.
    There are different uses for the measured values provided as above.
    One use is an adjustment of medication to a desired medication dose and / or type.
    The break time can be shortened by using medication as further demonstrated below.
    The above measurement can be performed before administering a medication, to give a first measurement value for mutual comparison. The medication is then taken by the subject. A certain time after this administration, a new measurement is made, which gives a second measurement value. The second measured value in relation to the first measured value gives a resultant effect of the medication. A shorter break is a clear indication of the effectiveness of the medication. 23 Different doses can thus be tested and the measured value documents the effect of the medication. The present method and apparatus thus provide a tool for an assessment or evaluation of drug effect.
    For example, the dosage may be increased after one week of medication, e.g. if no effect on pause time is measured. The dosage can thus be fine-tuned to an optimal level for a treatment window.
    The present method and apparatus thus provide a tool for adjusting medication to individual patient needs. related to oli- The effect of the medication on each individual component in Different components of the pause period, ka brain activities, can be identified individually. brain activity can thus be determined. The components are, for example, the above-mentioned time for memory retrieval and the time for recognizing stimuli.
    The present method and apparatus thus provide a tool for clinical drug testing.
    In addition, a subject who does not respond at all to medication can be identified (no change in pause time or In this way one can continue when eg components of the same). investigation begins, a tumor prevents the effectiveness of the medication.
    A method, apparatus or computer program as described in the unpublished application PCT / EPZOO8 / 064891 (diagnostics based on average speech pause time), by the same applicant as for the present application, which is incorporated herein in its entirety by reference to any damaal, effect on neuropsychiatric diseases. This was not thought to be possible for the diagnosis of medication possible at the time of submission of PCT / EP2008 / 064891, but has now been found to be feasible contrary to the prior view described in PCT / EPZOO8 / 064891. 24 Table 1 shows a result from a patient study conducted on 21 ADHD patients.
    Naming rate in ADHD patients (n = 21) evaluated in a drug-free condition and after 1 hour of methylphenidate treatment Agent. Std.av. Std.fe | Minimum Maximum t-value Signal level Total time 1 78.5 30.0 6.5 39.9 157.3 2 68.9 27.8 6.1 32.6 131.8 9.6 0.0013 Break time 1 403 23A 50 16fl 110J 2 32.2 21.2 4.6 11.3 79.9 8.1 0.0003 Talk time 1 aa: of 23 215 643 2 36.8 9.5 2.1 20.8 59.8 1.4 0.1140 1 = medication-free condition, 2 = after 1 hour of medication, paired t-test Table 1 When referring to “pause time” with reference to Table 1 and Figures 8-10, the term is directed towards the speech pause component in a cognitive naming, which should not be confused with the duration of the pause time measured above until the beginning of the articulation. However, after proving the effect of medication during the speech break, the applicants consider that medication will also have an effect on the duration of the break until the beginning of the articulation after the end of the stimulus display. Using the method and apparatus described above, the time for memory retrieval and recognition of stimuli is also determined.
    As shown in Table 1, the break time is significantly affected (improved) by the administered medication. However, the talk time (ie the articulation time) is not significantly affected, see the significance levels in Table 1, and Figures 8-10. Total time kelp after medication intake. The shortening of the total time (articulation plus break time) is also based mainly on shorter break time.
    In Figure 8, the duration of the pause period is plotted against the ages of four different groups of subjects. The graph shows that about half of the children with ADHD have durations of break time that are clearly above what is seen in healthy older people and in normal children. In addition, these children have similar durations of break time as those seen in patients with Alzheimer's disease.
    The graph in Figure 9 shows the difference in the duration of the break that is obtained at the baseline (medication-free condition) and after 1 hour of treatment with methylphenidate hydrochloride. The upper part of this figure shows the percentage distribution of the difference, while the lower part of the figure shows the change in each individual case. The majority of ADHD children show a significant reduction in the duration of the break during medication, in some cases the reduction is approximately 40 - 50%.
    Figure 10 shows a graph illustrating the difference in the pause time variability between a drug-free and a medicated condition in patients. The variability in pause time obtained in a drug-free condition (n = 13) is compared with the variability obtained after 1 hour of methylphenidate hydrochloride treatment. The upper part of the graph shows the percentile distribution, while the lower half of the graph shows each individual case. As can be seen, the variability in pause time is clearly reduced within the 75th and 90th percentiles. In these upper percentiles, the reduction in variability is 43 - 60%. The variability in pause time in Fig. 10 is defined here as the difference between the longest and shortest duration of the pause time obtained in 3 consecutive tests performed at the baseline and repeated 26 during medication. A reduction in variability thus indicates smaller differences between tests.
    The present invention has been described above with reference to specific embodiments. However, embodiments other than those described above are also possible within the scope of the invention. Method steps other than those described above, carrying out the method with hardware or software, can be provided within the scope of the invention. The various features and steps of the invention may be combined in combinations other than those described. The scope of the invention is limited only by the appended claims.
    权利要求:
    Claims (16)
    [1]
    An apparatus, arranged to diagnose disorders related to the brain of a subject, said apparatus comprising a display unit for displaying stimuli for said subject, a microphone for recording an audio signal, a control unit arranged to determine a time for recognizing a stimulus as a first pause time component, in a first working step, determining a memory retrieval time for a stimulus as a second pause time component, in a second working step and then subsequently displaying on said display unit a predefined number of different stimuli individually and in a sequence, each of the stimuli displayed during said time for recognition and with a display pause of predefined length between said individual displays and, after display of the last stimuli is completed, to measure a pause time before said subject's articulation begins in said sound signal for naming the displayed stimuli as quickly as possible and in said order f oiled, number of threads. in a third work step, a predefined one is repeated
    [2]
    Apparatus according to claim 1, comprising a scale having discrete intervals ranging from 0.1 to 1.0 seconds for adjusting the time for stimulus recognition with an input device such as a button.
    [3]
    Apparatus according to claim 1 or 2, comprising a START button arranged to start said display of stimuli in said third operating step. 10 15 20 25 30
    [4]
    The apparatus of claim 2, wherein said stimuli are a predefined number of different visual and / or auditory stimuli.
    [5]
    Apparatus according to any one of claims 1 to 4, wherein said time for recognizing a stimulus is determined by testing at which display time of stimulus the subject can identify and name the stimulus correctly.
    [6]
    The apparatus of claim 5, wherein said stimulus display time can be changed in discrete steps from a 0.1 second lower level to a 1.0 second maximum level, said recognition time being determined as the lowest level of correctness. identification of the stimulus through the correct verbal response from the subject.
    [7]
    Apparatus according to any one of claims 1 to 6, wherein said control unit is arranged to determine said memory retrieval time for a stimulus by displaying a plurality of said stimuli, each with the display time determined in the first step and in successive sequence with a time interval between them and, when the beginning of the last stimulus display has ended, recording said subject's speech and analyzing the pause time in said speech after said subject has named the stimulus correctly and in the correct order, and to calculate said time for memory retrieval as the average pause time for all stimuli divided by the number of stimuli.
    [8]
    An apparatus according to claim 7, wherein said control unit is arranged to repeat said determination of said memory retrieval time according to claim 7 for a second series of different stimuli. 10 15 20 25 30 35
    [9]
    An apparatus according to any one of claims 1 to 8, wherein said predefined number of different stimuli in said third working step is two.
    [10]
    Apparatus according to any one of claims 1 to 9, wherein said display pause is at least 0.1 seconds.
    [11]
    An apparatus according to any one of claims 1 to 10, wherein said individual stimuli as well as the order of display of the stimuli are randomized.
    [12]
    Apparatus according to any one of claims 1 to 11, comprising recording an audio signal at the beginning of the first stimulus and wherein the duration of the pause time to the first oral utterance of the first stimulus is determined from the recorded signal, and subtracting the display times for stimulus and the interstimulus interval from the recorded audio signal, providing a measure of the total pause duration and components thereof.
    [13]
    An apparatus according to any one of claims 1 to 12, wherein said apparatus is arranged to use said pause time and components thereof for diagnosing neu- including ADHD, or disorders induced by brain damage ropsychiatric disorders, autism spectrum disorders, in said subject.
    [14]
    An apparatus according to any one of claims 1 to 13, wherein said apparatus is arranged to use said pause time and components thereof for an adjustment of medication dose or type of medication to the individual patient needs of said subject.
    [15]
    An apparatus according to any one of claims 1 to 14, wherein said apparatus is arranged to use said pause time and components thereof for identifying subjects who do not respond to medication when no change in pause time occurs after administration of said medication.
    [16]
    An apparatus according to any one of claims 1 to 15, wherein said apparatus is arranged to use said pause time and components thereof for clinical drug testing and for evaluating and effecting said drug on a neuropsychiatric disorder, including ADHD, disorders within autism spectrum, or disorder caused by brain damage in said subject.
    类似技术:
    公开号 | 公开日 | 专利标题
    Katz et al.1992|Rapid automatized naming and gesture by normal and language-impaired children
    Serrallach et al.2016|Neural biomarkers for dyslexia, ADHD, and ADD in the auditory cortex of children
    Goverover et al.2007|The relationship between neuropsychological measures and the Timed Instrumental Activities of Daily Living task in multiple sclerosis
    Rabinowitz et al.2014|Association between finger tapping, attention, memory, and cognitive diagnosis in elderly patients
    Di Martino et al.2004|Methylphenidate for pervasive developmental disorders: safety and efficacy of acute single dose test and ongoing therapy: an open-pilot study
    Eden et al.1995|Temporal and spatial processing in reading disabled and normal children
    Ackermann et al.1999|Cerebellar contributions to the perception of temporal cues within the speech and nonspeech domain
    Babiloni et al.2018|Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study
    Mendez et al.2015|Virtual reality for the assessment of frontotemporal dementia, a feasibility study
    Laukka et al.2012|Preclinical cognitive trajectories differ for Alzheimer's disease and vascular dementia
    Dimauro et al.2016|VoxTester, software for digital evaluation of speech changes in Parkinson disease
    Morein-Zamir et al.2008|Novel measures of response performance and inhibition in children with ADHD
    EP2438863A1|2012-04-11|System and methods for analysis of pause time durations in speech.
    CN105658134A|2016-06-08|Multi-modal pharmaco-diagnostic assessment of brian helath
    WO2014152529A2|2014-09-25|Fmri biomarker of neurodegenerative disease
    Mioni2018|Methodological issues in the study of prospective timing
    SE0950299A1|2010-11-05|Device and method for voice based diagnostics
    Lee et al.2011|Speech Dysfluencies in Normal and Pathological Aging: A Comparison between Alzheimer Patients and Healthy Elderly Subjects.
    JP2019525817A|2019-09-12|Method and apparatus for screening and monitoring Alzheimer's disease using King Devic test
    Devalle et al.2018|Cardio-respiratory autonomic responses to nociceptive stimuli in patients with disorders of consciousness
    Fleischman et al.2009|Visuoperceptual repetition priming and progression of parkinsonian signs in aging
    RU2286805C2|2006-11-10|Method for correcting the development of communicative abilities in 1-yr-aged children
    Sedghizadeh et al.2020|Olfactory Response as a Marker for Alzheimer's Disease: Evidence from Perceptual and Frontal Oscillation Coherence Deficit
    Stothart et al.2020|A passive, objective and implicit measure of recognition memory in Alzheimer’s Disease using Fastball memory assessment.
    Karapetsas et al.2011|Event Related Potentials | in prognosis, diagnosis and rehabilitation of children with dyslexia
    同族专利:
    公开号 | 公开日
    US20120109005A1|2012-05-03|
    SE533963C2|2011-03-15|
    EP2457225A1|2012-05-30|
    EP2457225A4|2014-10-15|
    WO2010128934A1|2010-11-11|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US4543957A|1983-06-13|1985-10-01|Ernest H. Friedman|Human response apparatus and method|
    US5595488A|1994-08-04|1997-01-21|Vigilant Ltd.|Apparatus and method for monitoring and improving the alertness of a subject|
    US6435878B1|1997-02-27|2002-08-20|Bci, Llc|Interactive computer program for measuring and analyzing mental ability|
    US5911581A|1995-02-21|1999-06-15|Braintainment Resources, Inc.|Interactive computer program for measuring and analyzing mental ability|
    US6113393A|1997-10-29|2000-09-05|Neuhaus; Graham|Rapid automatized naming method and apparatus|
    US6884078B2|2002-09-17|2005-04-26|Harcourt Assessment, Inc.|Test of parietal lobe function and associated methods|
    AU2003900035A0|2003-01-07|2003-01-23|Monash University|Detecting subtle cognitive impairment|
    JP4635179B2|2004-09-24|2011-02-23|独立行政法人情報通信研究機構|Cognitive ability measuring device and cognitive ability measuring method|
    US20070218439A1|2005-12-15|2007-09-20|Posit Science Corporation|Cognitive training using visual searches|
    US20080057483A1|2006-09-05|2008-03-06|Lawrence H Avidan|Apparatus and System for Testing Memory|
    WO2009056650A1|2007-11-02|2009-05-07|Siegbert Warkentin|System and methods for assessment of the aging brain and its brain disease induced brain dysfunctions by speech analysis|
    US20110027765A1|2007-11-16|2011-02-03|San Diego State University Research Foundation|Methods for treating social disorders|EP2438863A1|2010-10-05|2012-04-11|Phibio Science AB|System and methods for analysis of pause time durations in speech.|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    SE0950299A|SE533963C2|2009-05-04|2009-05-04|Device and method for voice based diagnostics|SE0950299A| SE533963C2|2009-05-04|2009-05-04|Device and method for voice based diagnostics|
    US13/319,065| US20120109005A1|2009-05-04|2010-05-02|Apparatus and method for voice based diagnostic support|
    EP10772336.3A| EP2457225A4|2009-05-04|2010-05-02|Apparatus and method for voice based diagnostic support|
    PCT/SE2010/050480| WO2010128934A1|2009-05-04|2010-05-02|Apparatus and method for voice based diagnostic support|
    [返回顶部]